{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:04:08Z","timestamp":1784822648994,"version":"3.55.0"},"reference-count":132,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sphingolipid metabolism starts with the biosynthesis of ceramide, a bioactive lipid and the backbone for the biosynthesis of complex sphingolipids such as sphingomyelin and glycosphingolipids. These are degraded back to ceramide and then to sphingosine, which enters the ceramide\u2013sphingosine-1-phosphate signaling pathway or is further degraded. Several enzymes with multiple catalytic properties and subcellular localizations are thus involved in such metabolism. Hereditary defects of lysosomal hydrolases have been known for several years to be the cause of lysosomal storage diseases such as gangliosidoses, Gaucher disease, Niemann\u2013Pick disease, Krabbe disease, Fabry disease, and Farber disease. More recently, many other inborn errors of sphingolipid metabolism have been recognized, involving enzymes responsible for the biosynthesis of ceramide, sphingomyelin, and glycosphingolipids. Concurrently, epidemiologic and biochemical evidence has established a link between Gaucher disease and Parkinson\u2019s disease, showing that glucocerebrosidase variants predispose individuals to \u03b1-synuclein accumulation and neurodegeneration even in the heterozygous status. This appears to be due not only to lysosomal overload of non-degraded glucosylceramide, but to the derangement of vesicle traffic and autophagy, including mitochondrial autophagy, triggered by both sphingolipid intermediates and misfolded proteins. In this review, old and novel disorders of sphingolipid metabolism, in particular those of ganglioside biosynthesis, are evaluated in light of recent investigations of the link between Gaucher disease and Parkinson\u2019s disease, with the aim of better understanding their pathogenic mechanisms and addressing new potential therapeutic strategies.<\/jats:p>","DOI":"10.3390\/ijms20133304","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T11:44:16Z","timestamp":1562327056000},"page":"3304","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Link between Gaucher Disease and Parkinson\u2019s Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism"],"prefix":"10.3390","volume":"20","author":[{"given":"Rossella","family":"Indellicato","sequence":"first","affiliation":[{"name":"Department of Health Science, University of Milan, 20142 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0194-6933","authenticated-orcid":false,"given":"Marco","family":"Trinchera","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1515\/hsz-2017-0148","article-title":"The sphingomyelin synthase family: proteins, diseases, and inhibitors","volume":"398","author":"Chen","year":"2017","journal-title":"Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17505","DOI":"10.1074\/jbc.RA118.002048","article-title":"Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels","volume":"293","author":"Hayashi","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/scdb.1998.0256","article-title":"Protein and lipid sorting between the endoplasmic reticulum and the Golgi complex","volume":"9","author":"Nickel","year":"1998","journal-title":"Seminars  Cell Dev. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Russo, D., Capolupo, L., Loomba, J.S., Sticco, L., and D\u2019Angelo, G. (2018). Glycosphingolipid metabolism in cell fate specification. J. Cell Sci., 131.","DOI":"10.1242\/jcs.219204"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1194\/jlr.R083915","article-title":"Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles","volume":"59","author":"Verderio","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85817","article-title":"SPTLC1 is mutated in hereditary sensory neuropathy, type 1","volume":"27","author":"Bejaoui","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2018.05.008","article-title":"Hereditary sensory neuropathy type 1-associated deoxysphingolipids cause neurotoxicity, acute calcium handling abnormalities and mitochondrial dysfunction in vitro","volume":"117","author":"Wilson","year":"2018","journal-title":"Neu. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.ajhg.2017.05.003","article-title":"Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma","volume":"100","author":"Boyden","year":"2017","journal-title":"Am.J. Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.jid.2017.06.028","article-title":"Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia","volume":"137","author":"Takeichi","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3324\/haematol.2018.204784","article-title":"Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia","volume":"104","author":"Bariana","year":"2019","journal-title":"Haematologica"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24170","article-title":"Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy","volume":"76","author":"Vanni","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/mdc3.12610","article-title":"Progressive Myoclonic Epilepsy Type 8 Due to CERS1 Deficiency: A Novel Mutation with Prominent Ataxia","volume":"5","author":"Vale","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/jid.2013.153","article-title":"Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length","volume":"133","author":"Eckl","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/acn3.28","article-title":"Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy","volume":"1","author":"Mosbech","year":"2014","journal-title":"Ann. Clin. Trans. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.plipres.2016.03.006","article-title":"The enigma of ceramide synthase regulation in mammalian cells","volume":"63","author":"Wegner","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbamem.2017.01.019","article-title":"Phytosphingosine, sphingosine and dihydrosphingosine ceramides in model skin lipid membranes: permeability and biophysics","volume":"1859","author":"Skolova","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1172\/JCI123959","article-title":"Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy","volume":"129","author":"Pant","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI124159","article-title":"DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans","volume":"129","author":"Karsai","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pharep.2015.12.008","article-title":"Regulation of sphingomyelin metabolism","volume":"68","author":"Bienias","year":"2016","journal-title":"Pharmaco. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pekkinen, M., Terhal, P.A., Botto, L.D., Henning, P., Makitie, R.E., Roschger, P., Jain, A., Kol, M., Kjellberg, M.A., and Paschalis, E.P. (2019). Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2. JCI Insight, 4.","DOI":"10.1172\/jci.insight.126180"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/cge.13180","article-title":"Identification of a novel lethal form of autosomal recessive ichthyosis caused by UDP-glucose ceramide glucosyltransferase deficiency","volume":"93","author":"Monies","year":"2018","journal-title":"Clin. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ymgme.2018.06.014","article-title":"Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation","volume":"124","author":"Trinchera","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tig.2018.03.002","article-title":"Perspectives on Glycosylation and Its Congenital Disorders","volume":"34","author":"Ng","year":"2018","journal-title":"Trends Genet."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Riboldi, G.M., and Di Fonzo, A.B. (2019). GBA, Gaucher Disease, and Parkinson\u2019s Disease: From Genetic to Clinic to New Therapeutic Approaches. Cells, 8.","DOI":"10.3390\/cells8040364"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Woeste, M.A., and Wachten, D. (2017). The Enigmatic Role of GBA2 in Controlling Locomotor Function. Frontiers in Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00386"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13023-018-0845-z","article-title":"Acid ceramidase deficiency: Farber disease and SMA-PME","volume":"13","author":"Yu","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jmedgenet-2015-103457","article-title":"Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy","volume":"53","author":"Edvardson","year":"2016","journal-title":"J. Med. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1194\/jlr.S091827","article-title":"A perilous path: the inborn errors of sphingolipid metabolism","volume":"60","author":"Dunn","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/humu.22381","article-title":"Characterization of variants in the glucosylceramide synthase gene and their association with type 1 Gaucher disease severity","volume":"34","author":"Alfonso","year":"2013","journal-title":"Hum. Mutat."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/ene.13837","article-title":"Neurological effects of glucocerebrosidase gene mutations","volume":"26","author":"Mullin","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12311-016-0803-z","article-title":"Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks","volume":"16","author":"Bortholin","year":"2017","journal-title":"Cerebellum"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/epi.12050","article-title":"West syndrome caused by ST3Gal-III deficiency","volume":"54","author":"Edvardson","year":"2013","journal-title":"Epilepsia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B Niemann-Pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/1673-5374.228712","article-title":"Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage","volume":"13","author":"Folts","year":"2018","journal-title":"Neural Regen. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.msard.2019.01.040","article-title":"Misdiagnosis of multiple sclerosis in a female heterozygote with Fabry\u2019s disease","volume":"30","author":"Berger","year":"2019","journal-title":"Multiple sclerosis and related disorders"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.expneurol.2017.09.010","article-title":"Insights into the structural biology of Gaucher disease","volume":"298","author":"Smith","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"14319","DOI":"10.1016\/S0021-9258(17)38720-3","article-title":"Biosynthesis of the lysosomal enzyme glucocerebrosidase","volume":"260","author":"Erickson","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1016\/S0021-9258(18)82412-7","article-title":"Human acid beta-glucosidase. N-glycosylation site occupancy and the effect of glycosylation on enzymatic activity","volume":"268","author":"Grace","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"30063","DOI":"10.1074\/jbc.M114.593616","article-title":"The LIMP-2\/SCARB2 binding motif on acid beta-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseases","volume":"289","author":"Liou","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1073\/pnas.1514005113","article-title":"Characterization of the complex formed by beta-glucocerebrosidase and the lysosomal integral membrane protein type-2","volume":"113","author":"Zunke","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","article-title":"Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia","volume":"92","author":"Martin","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","article-title":"Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort","volume":"72","author":"Beavan","year":"2015","journal-title":"JAMA Neuro."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gatto, E.M., Da Prat, G., Etcheverry, J.L., Drelichman, G., and Cesarini, M. (2019). Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency. Brain Sci., 9.","DOI":"10.3390\/brainsci9020030"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JPD-171092","article-title":"Glucocerebrosidase Mutations in Parkinson Disease","volume":"7","author":"deSouza","year":"2017","journal-title":"J. Parkinson\u2019s Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mds.27631","article-title":"Emerging links between pediatric lysosomal storage diseases and adult parkinsonism","volume":"34","author":"Ysselstein","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/febs.14393","article-title":"The role of glucocerebrosidase in Parkinson disease pathogenesis","volume":"285","author":"Gegg","year":"2018","journal-title":"FEBS J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neurobiolaging.2018.02.028","article-title":"Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain","volume":"67","author":"Hallett","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.26802","article-title":"Lysosomal trafficking defects link Parkinson\u2019s disease with Gaucher\u2019s disease","volume":"31","author":"Wong","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41419-018-0816-2","article-title":"Exosomal secretion of alpha-synuclein as protective mechanism after upstream blockage of macroautophagy","volume":"9","author":"Fussi","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/hmg\/ddz030","article-title":"GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson\u2019s disease","volume":"28","author":"Ikuno","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nbd.2018.09.015","article-title":"Path mediation analysis reveals GBA impacts Lewy body disease status by increasing alpha-synuclein levels","volume":"121","author":"Gundner","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.1616152114","article-title":"Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models","volume":"114","author":"Sardi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/hmg\/ddy105","article-title":"Acid ceramidase inhibition ameliorates alpha-synuclein accumulation upon loss of GBA1 function","volume":"27","author":"Kim","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1080\/15548627.2015.1086055","article-title":"GBA deficiency promotes SNCA\/alpha-synuclein accumulation through autophagic inhibition by inactivated PPP2A","volume":"11","author":"Du","year":"2015","journal-title":"Autophagy"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Thomas, R.E., Vincow, E.S., Merrihew, G.E., MacCoss, M.J., Davis, M.Y., and Pallanck, L.J. (2018). Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles. PLoS Genet., 14.","DOI":"10.1371\/journal.pgen.1007694"},{"key":"ref_62","first-page":"1048084","article-title":"The Association between E326K of GBA and the Risk of Parkinson\u2019s Disease","volume":"2018","author":"Huang","year":"2018","journal-title":"Parkinson\u2019s Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.biocel.2005.05.008","article-title":"Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher\u2019s disease","volume":"37","author":"Schmitz","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15548627.2018.1509818","article-title":"Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations","volume":"15","author":"Li","year":"2019","journal-title":"Autophagy"},{"key":"ref_65","first-page":"1696","article-title":"Modulation of beta-glucocerebrosidase increases alpha-synuclein secretion and exosome release in mouse models of Parkinson\u2019s disease","volume":"27","author":"Papadopoulos","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ymgme.2018.11.011","article-title":"Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective","volume":"126","author":"Thomas","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fphar.2017.00448","article-title":"Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises","volume":"8","author":"Mohamed","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/humu.23611","article-title":"Exploring genetic modifiers of Gaucher disease: The next horizon","volume":"39","author":"Davidson","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/14728222.2018.1517156","article-title":"Chaperone-mediated autophagy as a therapeutic target for Parkinson disease","volume":"22","author":"Campbell","year":"2018","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2890.e13","DOI":"10.1016\/j.neurobiolaging.2013.06.010","article-title":"Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson\u2019s disease","volume":"34","author":"Foo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/mds.27642","article-title":"SMPD1 mutations, activity, and alpha-synuclein accumulation in Parkinson\u2019s disease","volume":"34","author":"Alcalay","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2019.03.005","article-title":"Cytosolic glucosylceramide regulates endolysosomal function in Niemann-Pick type C disease","volume":"127","author":"Wheeler","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pediatrneurol.2017.05.022","article-title":"A New Patient With Intermediate Severe Salla Disease With Hypomyelination: A Literature Review for Salla Disease","volume":"74","author":"Barmherzig","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-018-0300-6","article-title":"Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgmr.2017.10.013","article-title":"Parkinson\u2019s disease prevalence in Fabry disease: A survey study","volume":"14","author":"Wise","year":"2018","journal-title":"Mol. Genet. Metab. reports"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2018.01.012","article-title":"Alpha galactosidase A activity in Parkinson\u2019s disease","volume":"112","author":"Alcalay","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Gene."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/ddx153","article-title":"Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury","volume":"26","author":"Folts","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/jnr.23751","article-title":"Beyond Krabbe\u2019s disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies","volume":"94","author":"Marshall","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Folts, C.J., Scott-Hewitt, N., Proschel, C., Mayer-Proschel, M., and Noble, M. (2016). Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity. PLoS Biol., 14.","DOI":"10.1371\/journal.pbio.1002583"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.expneurol.2016.07.011","article-title":"Accumulated alpha-synuclein affects the progression of GM2 gangliosidoses","volume":"284","author":"Suzuki","year":"2016","journal-title":"Exp. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3389\/fneur.2018.00857","article-title":"Parkinsonism in Inherited Metabolic Disorders: Key Considerations and Major Features","volume":"9","author":"Limphaibool","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Gaspar, R., Pallbo, J., Weininger, U., Linse, S., and Sparr, E. (2018). Ganglioside lipids accelerate alpha-synuclein amyloid formation. Biochim. Biophys. Acta Proteins proteomics.","DOI":"10.1016\/j.bbapap.2018.07.004"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1073\/pnas.1700465115","article-title":"GBA1 deficiency negatively affects physiological alpha-synuclein tetramers and related multimers","volume":"115","author":"Kim","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Schneider, J.S. (2018). Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson\u2019s disease. PloS ONE, 13.","DOI":"10.1371\/journal.pone.0199189"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Chan, R.B., Perotte, A.J., Zhou, B., Liong, C., Shorr, E.J., Marder, K.S., Kang, U.J., Waters, C.H., Levy, O.A., and Xu, Y. (2017). Elevated GM3 plasma concentration in idiopathic Parkinson\u2019s disease: A lipidomic analysis. PloS ONE, 12.","DOI":"10.1371\/journal.pone.0172348"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"29227","DOI":"10.1016\/S0021-9258(19)62034-X","article-title":"Cloned beta 1,4 N-acetylgalactosaminyltransferase synthesizes GA2 as well as gangliosides GM2 and GD2. GM3 synthesis has priority over GA2 synthesis for utilization of lactosylceramide substrate in vivo","volume":"269","author":"Lutz","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1042\/bj3030957","article-title":"beta 1-4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: isolation and characterization of a beta 1-4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma cell line AH7974F","volume":"303","author":"Hidari","year":"1994","journal-title":"Biochem. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajhg.2013.05.006","article-title":"Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia","volume":"93","author":"Boukhris","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/brain\/awt270","article-title":"Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis","volume":"136","author":"Harlalka","year":"2013","journal-title":"Brain"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/cge.12312","article-title":"Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia","volume":"86","author":"Wakil","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuroscience.2018.11.034","article-title":"Loss of Enzyme Activity in Mutated B4GALNT1 Gene Products in Patients with Hereditary Spastic Paraplegia Results in Relatively Mild Neurological Disorders: Similarity with Phenotypes of B4galnt1 Knockout Mice","volume":"397","author":"Bhuiyan","year":"2019","journal-title":"Neuroscience"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","article-title":"Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects","volume":"96","author":"Sheikh","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1073\/pnas.93.20.10662","article-title":"Mice with disrupted GM2\/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system","volume":"93","author":"Takamiya","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"E1251","DOI":"10.1002\/humu.21205","article-title":"Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35)","volume":"31","author":"Dick","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2009.12.004","article-title":"Fatty acid 2-Hydroxylation in mammalian sphingolipid biology","volume":"1801","author":"Hama","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.celrep.2018.05.098","article-title":"Inhibition of Lysosome Membrane Recycling Causes Accumulation of Gangliosides that Contribute to Neurodegeneration","volume":"23","author":"Boutry","year":"2018","journal-title":"Cell Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2018.01.002","article-title":"Ganglioside Metabolism in Health and Disease","volume":"156","author":"Sandhoff","year":"2018","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/glycob\/cwy112","article-title":"Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylation","volume":"29","author":"Indellicato","year":"2019","journal-title":"Glycobiology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/ng1460","article-title":"Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase","volume":"36","author":"Simpson","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/hmg\/ddt434","article-title":"A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation","volume":"23","author":"Boccuto","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/ajmg.a.37773","article-title":"GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome-like phenotype","volume":"170","author":"Lee","year":"2016","journal-title":"Am. J. Med. Geneti. Part A"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Bowser, L.E., Young, M., Wenger, O.K., Ammous, Z., Brigatti, K.W., Carson, V.J., Moser, T., Deline, J., Aoki, K., and Morlet, T. (2019). Recessive GM3 synthase deficiency: Natural history, biochemistry, and therapeutic frontier. Mol. Genet. Metab.","DOI":"10.1016\/j.ymgme.2019.01.013"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.bbagen.2017.06.007","article-title":"Glycolipids: Essential regulator of neuro-inflammation, metabolism and gliomagenesis","volume":"1861","author":"Furukawa","year":"2017","journal-title":"Biochim. Biophys. Acta General subjects"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1073\/pnas.0635898100","article-title":"Enhanced insulin sensitivity in mice lacking ganglioside GM3","volume":"100","author":"Yamashita","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"9483","DOI":"10.1073\/pnas.0903279106","article-title":"Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti","volume":"106","author":"Yoshikawa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biocel.2009.09.010","article-title":"Differential expression of alpha-2,3-sialyltransferases and alpha-1,3\/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells","volume":"42","author":"Carvalho","year":"2010","journal-title":"The international journal of biochemistry & cell biology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/bbrc.1993.1830","article-title":"Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase","volume":"194","author":"Kitagawa","year":"1993","journal-title":"Biochem Bioph Res Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/glycob\/7.4.469","article-title":"Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression","volume":"7","author":"Kono","year":"1997","journal-title":"Glycobiology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/glycob\/cws103","article-title":"Biosynthesis of the major brain gangliosides GD1a and GT1b","volume":"22","author":"Sturgill","year":"2012","journal-title":"Glycobiology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1016\/j.bbagen.2016.08.005","article-title":"Unexpected distribution of CA19.9 and other type 1 chain Lewis antigens in normal and cancer tissues of colon and pancreas: Importance of the detection method and role of glycosyltransferase regulation","volume":"1861","author":"Aronica","year":"2017","journal-title":"Biochim. Biophys. Acta General subjects"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1096\/fj.13-236273","article-title":"Transcriptional control of the B3GALT5 gene by a retroviral promoter and methylation of distant regulatory elements","volume":"28","author":"Zulueta","year":"2014","journal-title":"FASEB J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biocel.2013.01.004","article-title":"CA19.9 antigen circulating in the serum of colon cancer patients: where is it from?","volume":"45","author":"Mare","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajhg.2011.08.008","article-title":"ST3GAL3 mutations impair the development of higher cognitive functions","volume":"89","author":"Hu","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41431-018-0220-5","article-title":"A patient-specific induced pluripotent stem cell model for West syndrome caused by ST3GAL3 deficiency","volume":"26","author":"Buettner","year":"2018","journal-title":"Eur.J. Hum. Geneti."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1182\/blood-2002-04-1007","article-title":"Sialyltransferase specificity in selectin ligand formation","volume":"100","author":"Ellies","year":"2002","journal-title":"Blood"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaci.2013.05.018","article-title":"Mice deficient in the St3gal3 gene product alpha2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation","volume":"133","author":"Kiwamoto","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","article-title":"Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities","volume":"93","author":"Menzies","year":"2017","journal-title":"Neuron"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1515\/hsz-2018-0237","article-title":"Sphingolipid metabolism\u2015An ambiguous regulator of autophagy in the brain","volume":"399","author":"Alam","year":"2018","journal-title":"Biological chemistry"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Qiang, L., Piermarini, E., and Baas, P.W. (2019). New Hypothesis for the Etiology of SPAST-based Hereditary Spastic Paraplegia. Cytoskeleton.","DOI":"10.1002\/cm.21528"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/ejhg.2012.202","article-title":"Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency","volume":"21","author":"Fragaki","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1471-4159.2008.05383.x","article-title":"Lipidomic analysis and electron transport chain activities in C57BL\/6J mouse brain mitochondria","volume":"106","author":"Kiebish","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10545-017-0048-0","article-title":"Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases","volume":"40","author":"Saffari","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biochi.2019.01.018","article-title":"Emergence of membrane sphingolipids as a potential therapeutic target","volume":"158","author":"Sahu","year":"2019","journal-title":"Biochimie"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2019.01.002","article-title":"Progranulin: A conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases","volume":"45","author":"Cui","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/gim.2017.133","article-title":"A cross-sectional quantitative analysis of the natural history of Farber disease: an ultra-orphan condition with rheumatologic and neurological cardinal disease features","volume":"20","author":"Zielonka","year":"2018","journal-title":"Genetet. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jbior.2016.10.002","article-title":"Ceramidases; roles in sphingolipid metabolism and in health and disease","volume":"63","author":"Coant","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1096\/fj.201700445RR","article-title":"Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates","volume":"32","author":"Li","year":"2018","journal-title":"FASEB J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"36898","DOI":"10.18632\/oncotarget.16370","article-title":"Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget","volume":"8","author":"Hatoum","year":"2017","journal-title":"Oncotarget"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1172\/JCI89626","article-title":"Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency","volume":"127","author":"Lovric","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/TACG.S146022","article-title":"Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype- phenotype correlations","volume":"12","author":"Oliveira","year":"2019","journal-title":"Appl. Clin. Genet."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/13\/3304\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:02:52Z","timestamp":1760187772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/13\/3304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":132,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2019,7]]}},"alternative-id":["ijms20133304"],"URL":"https:\/\/doi.org\/10.3390\/ijms20133304","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]}}}